- Home
- SKYH vs TSHA Comparison
SKYH vs TSHA Comparison
Compare SKYH & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYH
- TSHA
- Stock Information
- Founded
- SKYH 2017
- TSHA 2019
- Country
- SKYH United States
- TSHA United States
- Employees
- SKYH N/A
- TSHA N/A
- Industry
- SKYH Military/Government/Technical
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- SKYH Industrials
- TSHA Health Care
- Exchange
- SKYH Nasdaq
- TSHA Nasdaq
- Market Cap
- SKYH 389.8M
- TSHA 313.6M
- IPO Year
- SKYH N/A
- TSHA 2020
- Fundamental
- Price
- SKYH $11.36
- TSHA $1.53
- Analyst Decision
- SKYH Strong Buy
- TSHA Strong Buy
- Analyst Count
- SKYH 2
- TSHA 8
- Target Price
- SKYH $15.50
- TSHA $6.63
- AVG Volume (30 Days)
- SKYH 106.7K
- TSHA 2.3M
- Earning Date
- SKYH 11-12-2024
- TSHA 11-13-2024
- Dividend Yield
- SKYH N/A
- TSHA N/A
- EPS Growth
- SKYH N/A
- TSHA N/A
- EPS
- SKYH N/A
- TSHA N/A
- Revenue
- SKYH $12,357,000.00
- TSHA $9,915,000.00
- Revenue This Year
- SKYH $92.37
- TSHA N/A
- Revenue Next Year
- SKYH $116.98
- TSHA N/A
- P/E Ratio
- SKYH N/A
- TSHA N/A
- Revenue Growth
- SKYH 107.82
- TSHA N/A
- 52 Week Low
- SKYH $8.26
- TSHA $1.19
- 52 Week High
- SKYH $14.52
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- SKYH 42.32
- TSHA 34.16
- Support Level
- SKYH $10.83
- TSHA $1.56
- Resistance Level
- SKYH $11.68
- TSHA $1.75
- Average True Range (ATR)
- SKYH 0.36
- TSHA 0.15
- MACD
- SKYH -0.05
- TSHA -0.02
- Stochastic Oscillator
- SKYH 38.08
- TSHA 10.00
About SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.